BioTrove, Inc. Announces New OpenArray Platform Application to Identify Pediatric Respiratory Infectious Disease Agents

WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced its collaboration with Children’s Hospital of Eastern Ontario (CHEO) researchers in the evaluation of BioTrove’s OpenArray® technology as a system to detect and monitor respiratory infectious disease pathogens in children. The study combines BioTrove’s OpenArray nanofluidic polymerase chain reaction (PCR) technology platform with CHEO’s clinical and molecular biology expertise for rapid, simultaneous identification and quantification of multiple viral and bacterial respiratory pathogens in a clinical specimen.

MORE ON THIS TOPIC